Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

SZSE:301093 Stok Raporu

Piyasa değeri: CN¥2.8b

Jiangsu Hualan New Pharmaceutical MaterialLtd Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Jiangsu Hualan New Pharmaceutical MaterialLtd is forecast to grow earnings and revenue by 43.1% and 28% per annum respectively. EPS is expected to grow by 41% per annum. Return on equity is forecast to be 7.5% in 3 years.

Anahtar bilgiler

43.1%

Kazanç büyüme oranı

41.0%

EPS büyüme oranı

Medical Equipment kazanç büyümesi27.5%
Gelir büyüme oranı28.0%
Gelecekteki özkaynak getirisi7.5%
Analist kapsamı

Low

Son güncelleme07 Sep 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Sep 03
Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

Jun 07
Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

Kazanç ve Gelir Büyüme Tahminleri

SZSE:301093 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20261,158248N/A2431
12/31/2025898176N/A1911
12/31/2024722129N/A1671
9/30/20245928114215N/A
6/30/2024604953263N/A
3/31/202459395-6252N/A
12/31/2023623118-73224N/A
9/30/2023631106-124160N/A
6/30/202361998-118133N/A
3/31/202361096-129109N/A
1/1/202358494-7995N/A
9/30/202258610845178N/A
6/30/202269116490207N/A
3/31/2022784206114243N/A
1/1/202282121693217N/A
9/30/202178421466150N/A
6/30/202163315152116N/A
3/31/202150910361102N/A
12/31/20204468194133N/A
12/31/2019460955686N/A
12/31/20184348687107N/A
12/31/201738877N/A34N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 301093's forecast earnings growth (43.1% per year) is above the savings rate (2.9%).

Kazançlar ve Piyasa: 301093's earnings (43.1% per year) are forecast to grow faster than the CN market (25.8% per year).

Yüksek Büyüme Kazançları: 301093's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: 301093's revenue (28% per year) is forecast to grow faster than the CN market (14% per year).

Yüksek Büyüme Geliri: 301093's revenue (28% per year) is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 301093's Return on Equity is forecast to be low in 3 years time (7.5%).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y